Related Experiment Video
Updated: Aug 9, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression
Tomoya Nakamachi1, Min Li, Seiji Shioda
1U.S.-Japan Biomedical Research Laboratories, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Abstract:
Activity-dependent neurotrophic protein (ADNP) was discovered as a novel response gene for VIP and has neuroprotective potential. When the VIP paralog, PACAP38 was added to mouse neuron-glia co-cultures, it induced ADNP mRNA expression in a bimodal fashion at subpico- and nanomolar concentrations with greater response at subpicomolar level. The response was attenuated by a PAC1-R antagonist at both concentrations and by a VPAC1-R antagonist at nanomolar concentration only. An IP3/PLC inhibitor attenuated the response at both concentrations of PACAP38, but a MAPK inhibitor had no effect. A PKA inhibitor suppressed the response at nanomolar concentration only. These findings suggest that ADNP expression is mediated through multiple receptors and signaling pathways that are regulated by different concentrations of PACAP.
More Related Videos
Related Concept Videos
Endocrine Signaling
GPCRs Regulate Adenylyl Cylase Activity
Two...
Intracellular Signaling Cascades
IP3/DAG Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Amplifying Signals via Enzymatic Cascade

